News
Novo Nordisk (NYSE: NVO) stock had a Monday to forget, as news from a top rival dampened sentiment on the Danish ...
AQR Capital's Q1'25 portfolio hits $97.07B, with top picks in AAPL, NVDA, & AMZN. Active portfolio adjustments show a ...
Eli Lilly and Company (NYSE: LLY) is reportedly in advanced talks to acquire gene editing biotech Verve Therapeutics Inc.
Building the future of health care: the need for investment in radiopharmaceutical commercialization
The efforts of CNIC and CMIE are setting the stage for this future, ensuring that Canada remains at the cutting edge of ...
Eli Lilly is in advanced talks to acquire gene editing startup Verve Therapeutics for up to $1.3 billion, aiming to ...
As part of the deal, Eli Lilly would pay almost $1bn upfront for Verve, which is developing a gene-editing therapy to treat bad cholesterol, and a further $300mn based on the biotech company achieving ...
A third-party health insurance payer can proceed as a class in a racketeering lawsuit against Takeda Pharmaceuticals Co. and Eli Lilly & Co., a federal appeals panel ruled Monday.
Lilly the service dog embraced her new owner, 30-year decorated army veteran and Kansas City native, First Sgt. Michael Gainey.
Eli Lilly employees join forces for community service with Connecting Hearts at Home initiative in central Indiana, ...
In the closing of the recent trading day, Eli Lilly (LLY) stood at $807.58, denoting a -1.44% move from the preceding trading day.
WISH-TV on MSN5h
Lilly teams strengthen community tiesArchaeologists discover evidence of Roanoke colonists' fate after abandoning settlement Gina Gershon: ‘People like to cast me as a hardcore, motorcycle-riding, lesbian, man-killing demon’ "We're done" ...
By acquiring Rafael Devers, the San Francisco Giants put the pressure on all teams — including the Chicago Cubs — to show a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results